Finding a model, finding a cure

A major hurdle in the development of an animal model of hereditary breast cancer in humans has been overcome.

Breast cancer is the most prevalent type of cancer in women, with 192,000 new cases expected this year in the US alone. Despite extensive research efforts, scientists have been unable develop a mouse model of hereditary breast cancer. Until now.

As published in the May 15th issue of Genes & Development, a collaboration of researchers from Columbia University and the Dana-Farber Cancer Institute have generated a mouse strain with an inherited mutation in Brca1. The breast and ovarian cancer susceptibility gene, Brca1, is the most commonly detected genetic mutation in familial breast and ovarian cancer. Although structural analysis and in vitro cell culture studies have yielded some clues, the precise function of BRCA1 remains unknown. This work by Dr. Efstratiadis and colleagues represents an enormous advance in the determination of BRCA1 function in tumorigenesis.

Several previous attempts have been made to generate BRCA1-deficient mice. However, these attempts were unsuccessful due to the embryonic death of the mice that had two deficient copies of Brca1, and the fact that mice with only one defective copy of Brca1 did not develop tumors. Dr. Efstratiadis and colleagues modeled their experimental approach after a human breast cancer patient who had inherited homozygous mutations in Brca1 that presumably led to the production of a shortened, or truncated, BRCA1 protein. The scientists generated a mouse strain with a truncating Brca1 mutation that similarly eliminates the C-terminal portion of the BRCA1 protein.

These BRCA1 hypomorphic mice are viable, and they develop a variety of tumors, including breast tumors. As 1 in 9 women will be diagnosed with breast cancer in her lifetime, this work has widespread implications as a therapeutic and research model for hereditary breast cancer.


Contact: Nora Poppito
Cold Spring Harbor Laboratory

Page: 1

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. Finding the hole in the defenses of cavity-creating microbes
3. Findings redefine mechanism of action of RNA helicase enzymes
4. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
5. Finding may help eczema sufferers tolerate smallpox vaccine
6. Findings could aid efforts to harness nature for making drugs
7. Findings offer clue to how molecule can both stimulate, suppress cell growth
8. Findings offer further understanding about growth and development in young male gymnasts
9. Findings in frog oocytes may help study of chromosome physiology
10. Finding dirty bombs and other radiation threats
11. Finding life away from Earth will be tough task, says noted paleontologist

Post Your Comments:

(Date:8/26/2020)... and SHANGHAI (PRWEB) , ... August 24, 2020 ... ... novel approaches for the treatment of chronic inflammatory and fibrotic diseases, today announced ... and Vice President of Drug Discovery. , Dr. Canan previously served as Executive ...
(Date:8/26/2020)... , ... August 25, 2020 , ... Modality Solutions, ... Inc. magazine’s 2020 annual Inc. 5000 list. The list is the most prestigious ranking ... 2019 as well, and for this year’s list, reported three-year revenue growth of 71 ...
(Date:8/21/2020)... , ... August 19, 2020 , ... ... LLC and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty ... recently published book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , the leading ... Scientific Advisory Board (SAB) to research the medical potential of terpenes and the potential ... combined with terpenes. The board is focused on expanding the recently launched line of ...
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, ... it has closed on the purchase of greenfield for a new, expanded manufacturing ... includes over 21 acres in the initial acquisition, with an option to purchase ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... industry, today announced the release of its signature product called Beacon - ... (MSLs) and other field medical professionals. , Beacon helps MSLs streamline ...
Breaking Biology Technology:
Cached News: